06Oct 2025
New Drug Boosts Chemotherapy by Targeting Lipid Metabolism in Prostate Cancer

New Drug Boosts Chemotherapy by Targeting Lipid Metabolism in Prostate Cancer

Researchers discover that inhibiting SREBP-dependent lipogenesis with FGH10019 enhances docetaxel’s effectiveness in prostate cancer. Blocking lipid biosynthesis shifts cell membranes toward polyunsaturated lipids, increasing drug uptake and cancer cell death. This breakthrough suggests combining lipogenesis inhibitors with chemotherapy could improve treatment outcomes

  • #oncology
  • #urology

Like

Save

Share